(Q33908219)

29 July 2017

1 reference

title

Moderate-term, low-dose corticosteroids for rheumatoid arthritis (English)

1 reference

29 July 2017

0 references

1

L A Criswell

1 reference

29 July 2017

K G Saag

2

1 reference

29 July 2017

K M Sems

3

1 reference

29 July 2017

V Welch

4

1 reference

29 July 2017

B Shea

5

1 reference

29 July 2017

G Wells

6

1 reference

29 July 2017

M E Suarez-Almazor

7

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

published in

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

CD001158

1 reference

Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

SMALL DOSES OF PREDNISOLONE IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Single daily dose corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Corticosteroids in rheumatoid arthritis: is a trial of their 'disease modifying' potential feasible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

A method for assessing the quality of a randomized control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

The relative toxicity of disease-modifying antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

Corticosteroids in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001158

10.1002/14651858.CD001158

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference